APA (7th ed.) Citation

Swati Vyas, Sagar Dhoble, Vinod Ghodake, & V. Patravale. (2020). Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology. Elsevier.

Chicago Style (17th ed.) Citation

Swati Vyas, Sagar Dhoble, Vinod Ghodake, and V. Patravale. Xyloglucan Based Mucosal Nanovaccine for Immunological Protection Against Brucellosis Developed by Supercritical Fluid Technology. Elsevier, 2020.

MLA (9th ed.) Citation

Swati Vyas, et al. Xyloglucan Based Mucosal Nanovaccine for Immunological Protection Against Brucellosis Developed by Supercritical Fluid Technology. Elsevier, 2020.